Harrow, a leading North American eyecare pharmaceutical company, and Taiwan-based Formosa Pharmaceuticals (Formosa), announced a licensing agreement, whereby Harrow has acquired the exclusive US ...

National Institute of Mental Health and Neuro Sciences (NIMHANS) has been examining clinically relevant research questions among these representative, community-dwelling schizophrenia patients: these ...

WuXi Biologics, a leading global CRDMO, and VISEN Pharmaceuticals, an innovative biopharmaceutical company focused on endocrine diseases, announced that they will launch the technology transfer for ...

Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services, today announced the successful completion of its ...

OneSource's flagship drug-device combination facility maintains its US FDA compliance status: Our Bureau, Bengaluru Tuesday, June 10, 2025, 11:45 Hrs [IST] OneSource Specialty Pha ...

CII Telangana to hold ‘Pillars of Protection’ conference on pharma & chemical industries safety on June 25 at Hyderabad: Our Bureau, Bengaluru Tuesday, June 10, 2025, 09:00 Hr ...

Apollo Cradle & Children’s Hospital set for significant expansion, plans 7-8 new centres in the next five years: Our Bureau, Bengaluru Tuesday, June 10, 2025, 17:10 Hrs [IST] Ap ...

Sanofi accelerates global shipping of Beyfortus to prepare healthcare providers months ahead of 2025-2026 RSV season: Paris Tuesday, June 10, 2025, 11:00 Hrs [IST] Sanofi is shipp ...

Sanofi presents positive results from DISCOVER phase 4 study of Dupixent in atopic dermatitis patients with skin of colour at 2025 RAD conference: Paris Tuesday, June 10, 2025, 16 ...

Merck reports positive results from the first two phase 3 CORALreef trials of enlicitide decanoate to treat adults with hyperlipidemia: Rahway, New Jersey Tuesday, June 10, 2025, ...

Monash University to invest in a leading AI supercomputer to boost nation’s research capability: Our Bureau, Mumbai Tuesday, June 10, 2025, 17:20 Hrs [IST] Monash University wil ...

Everest Medicines presents positive results in preliminary analysis of phase 1b/2a trial of novel BTK inhibitor EVER001 at ERA 2025 Congress: Shanghai, China Tuesday, June 10, 202 ...